0001348362-25-000017.txt : 20251001 0001348362-25-000017.hdr.sgml : 20251001 20251001144631 ACCESSION NUMBER: 0001348362-25-000017 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251001 DATE AS OF CHANGE: 20251001 EFFECTIVENESS DATE: 20251001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lexaria Bioscience Corp. CENTRAL INDEX KEY: 0001348362 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 202000871 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-559470 FILM NUMBER: 251364107 BUSINESS ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 BUSINESS PHONE: 250-765-6424 MAIL ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 FORMER COMPANY: FORMER CONFORMED NAME: LEXARIA CORP. DATE OF NAME CHANGE: 20080229 FORMER COMPANY: FORMER CONFORMED NAME: Lexaria Corp. DATE OF NAME CHANGE: 20051229 D 1 primary_doc.xml X0708 D LIVE 0001348362 Lexaria Bioscience Corp. 100 - 740 MCCURDY ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 2P7 250-765-6424 NEVADA LEXARIA CORP. Lexaria Corp. Corporation true Christopher Bunka 100 - 740 McCurdy Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 2P7 Director John Docherty 100 - 740 McCurdy Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 2P7 Executive Officer Director Richard Christopher 100 - 740 McCurdy Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 2P7 Executive Officer Director Michael Shankman 100 - 740 McCurdy Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 2P7 Executive Officer Nicholas Baxter 100 - 740 McCurdy Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 2P7 Director William Edward McKechnie 100 - 740 McCurdy Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 2P7 Director Albert Reese 100 - 740 McCurdy Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 2P7 Director Bal Bhullar 100 - 740 McCurdy Road Kelowna A1 BRITISH COLUMBIA, CANADA V1X 2P7 Director Biotechnology $5,000,001 - $25,000,000 06b false 2025-09-29 false true false 0 H.C. WAINWRIGHT & CO. 375 None None 420 Park Avenue 4th Floor New York NY NEW YORK 10022 IL ILLINOIS NY NEW YORK true 4000000 4000000 0 false 5 280000 0 Commission represents 7% of the offering amount, including for the registered shares that form part of the combined offering of 1 registered share and 1 unregistered warrant 0 false Lexaria Bioscience Corp. /Richard Christopher/ Richard Christopher CEO 2025-10-01